The best indicator for Verisign (VRSN)
We backtested 20 indicators across daily, weekly and hourly charts on real Verisign (VRSN) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMA 50/200 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Verisign (VRSN) over ~28.3 years — beating buy-and-hold by 4.5% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | SMA 50/200 Cross ✓ | Daily | 19.8% | 0.67 | -65.8% | 70.6% | 17 | 4.5% |
| 2 | EMA 50/200 Cross ✓ | Daily | 18.4% | 0.64 | -61.3% | 58.8% | 17 | 3.2% |
| 3 | Donchian Breakout ✓ | Daily | 14.2% | 0.59 | -60.5% | 46.4% | 112 | -1.0% |
| 4 | EMA-10 Trend ✓ | Weekly | 13.3% | 0.55 | -75.8% | 45.3% | 128 | -1.8% |
| 5 | RSI Trend (>50) ✓ | Daily | 13.1% | 0.53 | -72.7% | 41.2% | 337 | -2.2% |
| 6 | Donchian Breakout ✓ | Weekly | 12.6% | 0.52 | -62.6% | 54.5% | 22 | -2.6% |
| 7 | Bollinger Breakout | Daily | 10.9% | 0.51 | -71.7% | 44.5% | 128 | -4.4% |
| 8 | Rate of Change ✓ | Weekly | 11.7% | 0.5 | -71.9% | 49.4% | 89 | -3.4% |
| 9 | EMA 20/50 Cross ✓ | Daily | 11.6% | 0.49 | -71.0% | 36.9% | 65 | -3.7% |
| 10 | RSI Trend (>50) ✓ | Weekly | 11.0% | 0.48 | -88.2% | 48.0% | 75 | -4.2% |
| 11 | ADX / DMI ✓ | Weekly | 10.6% | 0.47 | -61.5% | 48.8% | 41 | -4.6% |
| 12 | EMA 20/50 Cross ✓ | Weekly | 16.2% | 0.61 | -65.8% | 72.7% | 11 | 1.1% |
| 13 | MACD ✓ | Weekly | 9.2% | 0.44 | -91.2% | 45.5% | 55 | -5.9% |
| 14 | Heikin-Ashi Trend ✓ | Weekly | 9.0% | 0.43 | -90.6% | 49.6% | 244 | -6.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Verisign (VRSN), SMA 50/200 Cross on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.